190 filings
Page 2 of 10
8-K
b4xakrs8pe7dovs6u
22 Mar 23
Other Events
4:10pm
8-K
sako1
10 Feb 23
Termination of a Material Definitive Agreement
4:31pm
8-K
18wvlu2
7 Feb 23
Tenax Therapeutics Announces Pricing of Approximately $15.6 Million Public Offering
4:31pm
8-K
lq8ocsd
1 Feb 23
Patent is expected to provide additional intellectual property protection until 2040
4:46pm
8-K
f4q08m v5
20 Jan 23
Other Events
4:10pm
8-K
emy0 5t3gejtte
4 Jan 23
Tenax Therapeutics Announces Reverse Stock Split
5:05pm
8-K
dcxwu6zxzx4m
11 Oct 22
Positive Data Presented at HFSA Annual Meeting Demonstrate Effects of Oral
8:31am
8-K
snzdkt
20 Sep 22
Other Events
4:30pm
8-K
ch7gychyo4jvta9
15 Sep 22
Tenax Therapeutics Announces the Evaluation of Strategic Alternatives
9:00am
8-K
dgvj8i z8azc7
18 Aug 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
gpx3mt7d 1bg
16 Jun 22
Entry into a Material Definitive Agreement
4:35pm
8-K
spc0l54xb fkf176t
10 Jun 22
Departure of Directors or Certain Officers
4:31pm
8-K
ksj cpndv16zez6
23 May 22
Tenax Therapeutics Announces Successful
4:32pm
8-K
5rg5cga3q350tl1n1jf
20 May 22
Tenax Therapeutics Announces Certain Securities and Nasdaq Disclosures
4:30pm
8-K
02ys0jpt 3cid9rcm
24 Mar 22
Other Events
8:15am
8-K
agf qow2ggypvf2cpbz0
18 Feb 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:33pm
8-K
lbq7froy
31 Jan 22
Tenax Therapeutics Appoints Robyn Hunter to the Board of Directors
4:29pm
8-K
vrqnbu52sx3fzlse
28 Jan 22
Entry into a Material Definitive Agreement
4:16pm
8-K
vfl0w01p
24 Jan 22
TENAX THERAPEUTICS January 2022 I Corporate Presentation www.tenaxthera.com NASDAQ TENX
4:16pm
8-K
k23867
12 Jan 22
Tenax Therapeutics Granted U.S. Patent for the Subcutaneous
4:53pm